| 2.7 |
8.0 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 2.5 |
7.4 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 2.2 |
6.7 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
| 2.2 |
6.6 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 2.1 |
10.7 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 2.1 |
8.4 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 2.0 |
7.9 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 1.9 |
5.7 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 1.8 |
7.2 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 1.7 |
5.1 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 1.6 |
4.8 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 1.5 |
4.6 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 1.5 |
4.5 |
GO:0099547 |
regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.5 |
7.4 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 1.4 |
4.3 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 1.4 |
7.1 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 1.4 |
4.2 |
GO:1902287 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 1.4 |
8.4 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 1.4 |
1.4 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 1.3 |
6.7 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 1.3 |
4.0 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 1.3 |
3.9 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 1.2 |
13.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 1.2 |
3.6 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 1.2 |
3.6 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.2 |
7.1 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 1.2 |
3.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.2 |
8.1 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.1 |
3.4 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.1 |
7.8 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.1 |
3.3 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 1.1 |
1.1 |
GO:0086047 |
membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 1.1 |
3.2 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 1.1 |
5.3 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 1.1 |
5.3 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 1.0 |
5.2 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 1.0 |
4.2 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 1.0 |
1.0 |
GO:0060996 |
dendritic spine development(GO:0060996) |
| 1.0 |
14.4 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 1.0 |
4.1 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.0 |
1.0 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 1.0 |
6.1 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 1.0 |
3.0 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.0 |
1.9 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.0 |
3.9 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.9 |
1.9 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.9 |
6.6 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.9 |
3.8 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.9 |
1.8 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.9 |
5.5 |
GO:1903056 |
positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.9 |
0.9 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.9 |
4.5 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.9 |
0.9 |
GO:0086029 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.9 |
3.6 |
GO:0097393 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 0.9 |
3.5 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.9 |
1.8 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 0.9 |
5.3 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.9 |
1.7 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 0.9 |
6.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.9 |
4.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.9 |
7.7 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.8 |
2.5 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.8 |
11.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.8 |
4.2 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.8 |
2.5 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.8 |
4.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.8 |
3.3 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.8 |
2.4 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.8 |
2.4 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.8 |
0.8 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.8 |
2.4 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.8 |
0.8 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.8 |
0.8 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.8 |
3.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.8 |
5.4 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.8 |
0.8 |
GO:0099548 |
trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by nitric oxide(GO:0099548) |
| 0.8 |
6.2 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.8 |
7.6 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.7 |
5.1 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.7 |
2.2 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.7 |
7.3 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.7 |
4.3 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.7 |
2.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.7 |
2.9 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) regulation of testosterone secretion(GO:2000843) |
| 0.7 |
1.4 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.7 |
1.4 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.7 |
2.1 |
GO:0032430 |
inhibitory G-protein coupled receptor phosphorylation(GO:0002030) positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.7 |
0.7 |
GO:0061046 |
regulation of branching involved in lung morphogenesis(GO:0061046) |
| 0.7 |
2.8 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.7 |
3.5 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.7 |
2.1 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.7 |
2.8 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.7 |
0.7 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.7 |
2.1 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.7 |
2.7 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.7 |
4.8 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.7 |
2.0 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.7 |
2.7 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.7 |
10.9 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.7 |
3.3 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.7 |
1.3 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.7 |
6.7 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.7 |
0.7 |
GO:0032911 |
transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.7 |
3.3 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.7 |
2.6 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.7 |
1.3 |
GO:0031392 |
regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.7 |
2.0 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.6 |
4.5 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.6 |
0.6 |
GO:1904908 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.6 |
2.6 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.6 |
4.4 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.6 |
2.5 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.6 |
1.9 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.6 |
1.9 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.6 |
1.9 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.6 |
3.7 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.6 |
1.9 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.6 |
1.9 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.6 |
1.2 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.6 |
0.6 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.6 |
2.5 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.6 |
4.3 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) |
| 0.6 |
3.6 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.6 |
4.8 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.6 |
2.9 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.6 |
1.2 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.6 |
2.3 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.6 |
1.7 |
GO:2000331 |
regulation of terminal button organization(GO:2000331) |
| 0.6 |
1.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
1.2 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.6 |
15.0 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.6 |
1.7 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.6 |
2.3 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.6 |
1.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.6 |
3.4 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.6 |
1.7 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.6 |
1.7 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.6 |
9.0 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.6 |
1.1 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.6 |
3.9 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.6 |
1.7 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.6 |
1.7 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.6 |
2.2 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.5 |
1.1 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.5 |
2.2 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.5 |
0.5 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.5 |
1.6 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.5 |
8.6 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.5 |
1.1 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 0.5 |
1.6 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.5 |
2.1 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 |
0.5 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.5 |
1.6 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.5 |
1.6 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.5 |
3.6 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.5 |
3.6 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.5 |
1.6 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.5 |
1.6 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.5 |
2.1 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.5 |
5.7 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.5 |
1.0 |
GO:1903294 |
regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 0.5 |
4.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.5 |
1.5 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.5 |
1.5 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.5 |
3.6 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.5 |
1.0 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.5 |
0.5 |
GO:0070103 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.5 |
1.5 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.5 |
2.0 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.5 |
1.5 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.5 |
1.5 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.5 |
1.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.5 |
1.5 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.5 |
2.0 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.5 |
1.5 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.5 |
3.0 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.5 |
2.4 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.5 |
1.5 |
GO:0031554 |
regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.5 |
1.0 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.5 |
0.5 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.5 |
2.9 |
GO:0043622 |
cortical microtubule organization(GO:0043622) |
| 0.5 |
0.5 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.5 |
1.4 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.5 |
1.0 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.5 |
1.4 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.5 |
2.8 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.5 |
1.4 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.5 |
0.9 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.5 |
3.8 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.5 |
5.1 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.5 |
3.7 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.5 |
0.5 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.5 |
5.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.5 |
0.5 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) |
| 0.5 |
1.8 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.5 |
4.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.5 |
8.6 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.5 |
0.9 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.5 |
1.4 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.5 |
1.4 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.5 |
3.6 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.4 |
1.8 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 |
0.9 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.4 |
1.3 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.4 |
0.4 |
GO:0051311 |
meiotic metaphase plate congression(GO:0051311) |
| 0.4 |
0.9 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.4 |
0.9 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.4 |
2.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.4 |
2.2 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.4 |
2.2 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.4 |
1.3 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
| 0.4 |
3.0 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.4 |
2.5 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.4 |
1.7 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.4 |
2.1 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.4 |
0.4 |
GO:0022410 |
circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.4 |
1.3 |
GO:0061075 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.4 |
1.3 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.4 |
1.3 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.4 |
0.4 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.4 |
1.3 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.4 |
2.9 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.4 |
1.2 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.4 |
1.7 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.4 |
1.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.4 |
0.4 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.4 |
0.8 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.4 |
1.6 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.4 |
1.2 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.4 |
0.4 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.4 |
0.4 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.4 |
2.4 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 |
1.6 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.4 |
1.2 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.4 |
3.1 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.4 |
1.9 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.4 |
1.9 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 |
3.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 |
0.4 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.4 |
3.1 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.4 |
3.0 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.4 |
0.4 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.4 |
1.5 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.4 |
4.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.4 |
1.9 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.4 |
1.5 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.4 |
0.7 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.4 |
1.1 |
GO:0098885 |
actin filament bundle distribution(GO:0070650) modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 0.4 |
1.5 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.4 |
1.1 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.4 |
2.5 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.4 |
1.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.4 |
0.4 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.4 |
2.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 |
3.9 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.4 |
1.8 |
GO:0034350 |
regulation of glial cell apoptotic process(GO:0034350) |
| 0.4 |
6.0 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.4 |
3.2 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.4 |
2.8 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.4 |
1.8 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
1.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.3 |
1.7 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.3 |
0.7 |
GO:0071380 |
cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.3 |
2.4 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.3 |
3.1 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 |
1.4 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
0.3 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.3 |
0.7 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.3 |
0.7 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.3 |
1.7 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.3 |
1.0 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.3 |
8.2 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.3 |
3.1 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.3 |
2.0 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.3 |
1.0 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.3 |
1.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 |
1.4 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.3 |
0.3 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.3 |
1.7 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 |
2.3 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 0.3 |
0.3 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.3 |
3.7 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.3 |
2.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.3 |
1.3 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.3 |
0.7 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.3 |
2.0 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.3 |
1.6 |
GO:0034349 |
glial cell apoptotic process(GO:0034349) |
| 0.3 |
4.6 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.3 |
0.3 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 |
1.9 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.3 |
1.0 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.3 |
3.2 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.3 |
0.3 |
GO:0042321 |
negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
| 0.3 |
4.5 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.3 |
1.0 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.3 |
7.0 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.3 |
1.6 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.3 |
1.0 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.3 |
1.0 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.3 |
0.6 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.3 |
0.6 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.3 |
2.2 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.3 |
0.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.3 |
0.3 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.3 |
3.4 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.3 |
0.6 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.3 |
0.3 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.3 |
1.5 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.3 |
1.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.3 |
2.4 |
GO:2000232 |
regulation of rRNA processing(GO:2000232) |
| 0.3 |
3.3 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.3 |
2.4 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.3 |
0.9 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.3 |
2.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.3 |
2.4 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.3 |
0.9 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.3 |
1.8 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.3 |
1.2 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.3 |
0.6 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.3 |
0.9 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 |
3.9 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.3 |
0.3 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.3 |
1.2 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
0.6 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.3 |
0.9 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.3 |
0.3 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.3 |
0.6 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.3 |
2.6 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.3 |
0.9 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.3 |
2.0 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.3 |
1.4 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.3 |
1.1 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.3 |
0.6 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.3 |
1.4 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.3 |
0.8 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.3 |
0.8 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.3 |
1.7 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.3 |
1.1 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.3 |
0.8 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.3 |
1.9 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.3 |
0.3 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.3 |
0.3 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.3 |
1.9 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.3 |
0.5 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.3 |
0.5 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.3 |
2.7 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.3 |
2.2 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.3 |
1.6 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.3 |
1.1 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
1.1 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.3 |
0.8 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
0.5 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.3 |
0.8 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.3 |
1.1 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.3 |
0.8 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.3 |
0.5 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 |
0.5 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.3 |
0.5 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.3 |
1.6 |
GO:0002724 |
regulation of T cell cytokine production(GO:0002724) positive regulation of T cell cytokine production(GO:0002726) |
| 0.3 |
2.6 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.3 |
3.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.3 |
1.3 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.3 |
1.8 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.3 |
0.3 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.3 |
1.3 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.3 |
3.1 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
1.3 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.3 |
7.6 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.3 |
1.6 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.3 |
2.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.3 |
0.5 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) |
| 0.3 |
1.0 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.3 |
0.8 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 |
8.0 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.3 |
1.5 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.3 |
1.0 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.3 |
0.5 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.3 |
0.8 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 |
1.3 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.3 |
0.5 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.3 |
1.3 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.3 |
0.3 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.3 |
0.8 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 |
0.5 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.3 |
1.5 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.3 |
1.8 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.3 |
0.3 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) |
| 0.2 |
2.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 |
0.7 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.2 |
1.0 |
GO:1904528 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.2 |
1.5 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 |
2.7 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.2 |
1.5 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 0.2 |
1.0 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
0.7 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.2 |
0.2 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.2 |
2.7 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 |
0.5 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.2 |
0.7 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.2 |
1.2 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.7 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
2.8 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 |
2.1 |
GO:0007143 |
female meiotic division(GO:0007143) |
| 0.2 |
0.9 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.2 |
0.7 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.2 |
0.7 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.2 |
1.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.2 |
0.9 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
0.5 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 |
0.7 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
| 0.2 |
0.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
0.5 |
GO:0051177 |
meiotic sister chromatid cohesion(GO:0051177) |
| 0.2 |
0.2 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 |
0.7 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
1.8 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
1.4 |
GO:0051231 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
| 0.2 |
1.6 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.2 |
0.2 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.2 |
0.5 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.2 |
2.0 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 |
1.4 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.2 |
1.8 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.2 |
2.0 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
0.5 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.2 |
0.7 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.2 |
0.7 |
GO:0030818 |
negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.2 |
0.7 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.2 |
0.4 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 |
0.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.2 |
0.9 |
GO:0060903 |
regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
| 0.2 |
1.6 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
0.7 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 0.2 |
0.9 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.2 |
0.9 |
GO:0097104 |
postsynaptic membrane assembly(GO:0097104) |
| 0.2 |
0.7 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.2 |
0.9 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 |
0.7 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.2 |
0.7 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 |
5.0 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 |
2.0 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
1.3 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.2 |
3.0 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.2 |
0.9 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 |
0.7 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.2 |
0.6 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.2 |
1.5 |
GO:0006312 |
mitotic recombination(GO:0006312) |
| 0.2 |
1.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.2 |
0.6 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 |
0.2 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 |
1.5 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.2 |
6.9 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.2 |
0.6 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 0.2 |
0.6 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.2 |
0.8 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.2 |
1.5 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 |
0.2 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.2 |
1.0 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.2 |
0.6 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.2 |
0.6 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.2 |
0.6 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.2 |
3.1 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.2 |
1.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
1.0 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 |
1.2 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.2 |
0.6 |
GO:0032204 |
regulation of telomere maintenance(GO:0032204) |
| 0.2 |
0.2 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.2 |
1.4 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
0.2 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.2 |
0.6 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.2 |
1.8 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.2 |
1.0 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.2 |
1.2 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
0.4 |
GO:0014832 |
urinary bladder smooth muscle contraction(GO:0014832) |
| 0.2 |
0.4 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 0.2 |
1.0 |
GO:0046512 |
sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.2 |
1.3 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.2 |
1.0 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 |
2.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
1.3 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
0.8 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 |
0.8 |
GO:1904377 |
positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.2 |
2.8 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 |
0.2 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.2 |
1.5 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
0.2 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.2 |
3.4 |
GO:0090307 |
mitotic spindle assembly(GO:0090307) |
| 0.2 |
0.2 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.2 |
2.4 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.2 |
0.6 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.2 |
4.5 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
1.1 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
0.9 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.2 |
0.4 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.2 |
0.6 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.2 |
1.1 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
1.5 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
0.4 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
1.1 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.2 |
1.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.2 |
1.6 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
3.1 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.2 |
0.5 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.2 |
0.7 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 |
0.4 |
GO:0046958 |
nonassociative learning(GO:0046958) habituation(GO:0046959) |
| 0.2 |
0.5 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 |
0.9 |
GO:0032682 |
negative regulation of chemokine production(GO:0032682) |
| 0.2 |
0.5 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.2 |
0.4 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 |
0.2 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) |
| 0.2 |
1.2 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.2 |
0.9 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 0.2 |
0.5 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.2 |
2.0 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 |
1.4 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 |
0.5 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
1.8 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.2 |
2.5 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.2 |
0.2 |
GO:0001840 |
neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 |
2.6 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 |
0.2 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.2 |
1.7 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 |
0.5 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.2 |
1.5 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.2 |
0.8 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.2 |
0.5 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
0.7 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 |
0.8 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) |
| 0.2 |
1.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
1.0 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.2 |
0.2 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.2 |
0.2 |
GO:0098707 |
ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 |
0.2 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 |
1.0 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.2 |
0.2 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.2 |
3.0 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.2 |
1.0 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
1.8 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.2 |
0.3 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
0.3 |
GO:1903431 |
positive regulation of cell maturation(GO:1903431) |
| 0.2 |
0.3 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.2 |
0.8 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.2 |
2.1 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 |
0.6 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.2 |
0.6 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
1.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
0.5 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.2 |
0.8 |
GO:1900119 |
regulation of execution phase of apoptosis(GO:1900117) positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
0.2 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.2 |
4.5 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.2 |
0.8 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 |
0.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
0.8 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.2 |
0.3 |
GO:1905049 |
negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 |
0.2 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.2 |
0.3 |
GO:0045188 |
regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.2 |
0.6 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.2 |
1.1 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.2 |
0.2 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 |
0.6 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.2 |
1.4 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 |
0.2 |
GO:0045687 |
positive regulation of glial cell differentiation(GO:0045687) |
| 0.2 |
0.5 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.2 |
1.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
1.1 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 |
0.5 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.2 |
0.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.2 |
4.2 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.2 |
0.2 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.2 |
0.9 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
1.2 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
0.7 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.4 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.1 |
0.9 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.6 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.6 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.4 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
1.0 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.1 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.7 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.6 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
2.5 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
0.4 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.4 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.7 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.1 |
5.3 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.1 |
0.7 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.3 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.1 |
1.6 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.4 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.3 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.1 |
1.0 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.4 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.1 |
0.1 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
4.6 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.7 |
GO:0045910 |
negative regulation of DNA recombination(GO:0045910) |
| 0.1 |
3.5 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.1 |
0.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
1.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
2.4 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 |
0.3 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.1 |
0.8 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.7 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.1 |
0.7 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.7 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 |
0.5 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.1 |
2.7 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 |
0.7 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.1 |
1.3 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.3 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.1 |
0.3 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 |
2.9 |
GO:0045576 |
mast cell activation(GO:0045576) |
| 0.1 |
0.4 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.3 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 |
0.4 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.1 |
0.9 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.5 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.1 |
1.3 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.1 |
2.1 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.1 |
0.8 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.1 |
0.9 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.8 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.1 |
GO:1900377 |
regulation of secondary metabolic process(GO:0043455) negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 |
2.4 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
1.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
1.2 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.5 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.5 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 |
1.7 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 |
0.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 |
0.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.7 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
0.7 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.2 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.9 |
GO:0036093 |
germ cell proliferation(GO:0036093) |
| 0.1 |
0.1 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.1 |
0.4 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
2.8 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
0.6 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
1.2 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 |
0.4 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.7 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
2.5 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
1.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.4 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
1.5 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
0.5 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.4 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
0.2 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
0.2 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 |
2.9 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.1 |
0.1 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.1 |
0.8 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
1.3 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.1 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.2 |
GO:0002890 |
negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
| 0.1 |
0.8 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.7 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
2.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.3 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.7 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.5 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.1 |
0.2 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.1 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.1 |
1.6 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.1 |
0.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
0.7 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
0.4 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.1 |
0.9 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
0.4 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.1 |
0.9 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
7.7 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
0.9 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.2 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 |
1.6 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.2 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.1 |
0.3 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
0.5 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.1 |
GO:2000510 |
positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 |
1.1 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.7 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 |
0.3 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 |
0.6 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.1 |
1.2 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.1 |
0.4 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.1 |
0.6 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.1 |
5.2 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
0.5 |
GO:0051657 |
maintenance of organelle location(GO:0051657) |
| 0.1 |
0.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.6 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
1.6 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.5 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.4 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.3 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.1 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 |
0.1 |
GO:0072103 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.1 |
0.3 |
GO:0044557 |
relaxation of smooth muscle(GO:0044557) |
| 0.1 |
0.7 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.3 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.1 |
0.6 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.5 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.9 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.2 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 |
0.3 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 |
0.3 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.1 |
0.3 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.4 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.2 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.1 |
2.7 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.1 |
0.1 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 0.1 |
0.3 |
GO:0060449 |
bud elongation involved in lung branching(GO:0060449) |
| 0.1 |
1.6 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.1 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.1 |
0.6 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.2 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.1 |
0.5 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.1 |
0.7 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.8 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.3 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 |
2.5 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.5 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
1.2 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.1 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.1 |
0.3 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 |
0.2 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.1 |
0.8 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.5 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.1 |
0.1 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 |
1.1 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 |
2.5 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.8 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
1.2 |
GO:0043506 |
regulation of JUN kinase activity(GO:0043506) |
| 0.1 |
1.7 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
0.3 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.4 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.3 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) myelin maintenance(GO:0043217) |
| 0.1 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 |
1.1 |
GO:1902254 |
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.1 |
0.2 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.2 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 |
0.3 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.5 |
GO:0043584 |
nose development(GO:0043584) |
| 0.1 |
0.3 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.8 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.1 |
0.6 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.5 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.1 |
0.1 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.1 |
1.9 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.3 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
0.2 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 |
0.9 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.8 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.1 |
0.3 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.1 |
0.7 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.1 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.1 |
0.7 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.3 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
0.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.2 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.1 |
0.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.2 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.1 |
1.0 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
1.5 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.1 |
0.2 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.1 |
0.2 |
GO:1903236 |
negative regulation of cellular extravasation(GO:0002692) regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
1.5 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.3 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
0.2 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.1 |
0.2 |
GO:0032527 |
protein exit from endoplasmic reticulum(GO:0032527) |
| 0.1 |
0.2 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
0.2 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.1 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 |
0.1 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 |
0.1 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.5 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.3 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.7 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
7.5 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) |
| 0.1 |
0.1 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 |
0.4 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
| 0.1 |
1.0 |
GO:1904816 |
regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 |
0.6 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.1 |
0.2 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
0.3 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
0.3 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.1 |
0.1 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.2 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 |
0.1 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 |
1.0 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.7 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.2 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.1 |
0.9 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.2 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 |
0.2 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
1.4 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
0.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
1.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.1 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
1.0 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 |
0.8 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.1 |
0.3 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.1 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.1 |
GO:0035482 |
gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.1 |
0.2 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.2 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
1.5 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
0.1 |
GO:0034143 |
regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.1 |
1.3 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.1 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.1 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.2 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
7.7 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
0.7 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.1 |
0.5 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.1 |
0.2 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.3 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.6 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.4 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.1 |
0.1 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 |
0.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.6 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.1 |
0.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.2 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.6 |
GO:0090174 |
organelle membrane fusion(GO:0090174) |
| 0.1 |
0.4 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
1.4 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.1 |
0.4 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
5.3 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
0.2 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.1 |
0.8 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.2 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.2 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.2 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.1 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.1 |
0.2 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 |
0.1 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.4 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
0.1 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.1 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.1 |
0.4 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.2 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 |
0.7 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.6 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.2 |
GO:0098706 |
ferric iron import(GO:0033216) iron ion import(GO:0097286) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 |
0.5 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.1 |
0.1 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.1 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.1 |
0.1 |
GO:0099625 |
ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.1 |
0.1 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.4 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.4 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.2 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.1 |
0.1 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.3 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
0.2 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.1 |
0.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.2 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
0.3 |
GO:0051189 |
molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 |
0.4 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.1 |
0.5 |
GO:0090382 |
phagosome maturation(GO:0090382) |
| 0.1 |
0.5 |
GO:0032438 |
melanosome organization(GO:0032438) |
| 0.1 |
0.1 |
GO:0002886 |
regulation of myeloid leukocyte mediated immunity(GO:0002886) |
| 0.1 |
0.4 |
GO:0002921 |
negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.1 |
0.2 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
1.0 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.1 |
0.2 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.1 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.0 |
0.5 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.0 |
0.0 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.1 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.1 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.0 |
0.1 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 |
0.1 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 |
0.3 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.0 |
0.1 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.0 |
0.1 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 |
0.3 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.1 |
GO:0046519 |
sphingoid metabolic process(GO:0046519) |
| 0.0 |
0.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.0 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.2 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.2 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.2 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 |
0.0 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.1 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.3 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.2 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.0 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 |
0.3 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.0 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.5 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.2 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 |
0.4 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.1 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.6 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.1 |
GO:0090314 |
positive regulation of protein targeting to membrane(GO:0090314) |
| 0.0 |
1.6 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.1 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.0 |
0.2 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.0 |
0.2 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
0.4 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.2 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.0 |
0.1 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.1 |
GO:0032640 |
tumor necrosis factor production(GO:0032640) tumor necrosis factor superfamily cytokine production(GO:0071706) |
| 0.0 |
0.1 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.0 |
0.0 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.0 |
0.0 |
GO:1903897 |
PERK-mediated unfolded protein response(GO:0036499) regulation of PERK-mediated unfolded protein response(GO:1903897) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.0 |
0.1 |
GO:0006677 |
glycosylceramide metabolic process(GO:0006677) |
| 0.0 |
0.2 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.0 |
0.1 |
GO:0046073 |
dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.0 |
1.5 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.2 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.1 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.0 |
0.4 |
GO:0006110 |
regulation of glycolytic process(GO:0006110) |
| 0.0 |
0.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.0 |
0.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.1 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.0 |
0.0 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.1 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.1 |
GO:0002455 |
humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 |
0.1 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.1 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.1 |
GO:2000288 |
positive regulation of myoblast proliferation(GO:2000288) |
| 0.0 |
0.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.2 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
0.1 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 |
0.1 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.0 |
0.1 |
GO:0090224 |
regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.0 |
0.0 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.5 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.1 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.0 |
0.0 |
GO:0033146 |
regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.0 |
0.6 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.5 |
GO:0050685 |
positive regulation of mRNA processing(GO:0050685) |
| 0.0 |
0.4 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.0 |
0.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.0 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.1 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.1 |
GO:2000407 |
T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
| 0.0 |
0.1 |
GO:0086103 |
G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.0 |
0.2 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) |
| 0.0 |
0.1 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.0 |
0.3 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.0 |
0.1 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.0 |
0.1 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.0 |
0.1 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.0 |
0.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.1 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.0 |
0.0 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.0 |
0.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.1 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.1 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.0 |
0.1 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) nucleobase catabolic process(GO:0046113) |
| 0.0 |
0.0 |
GO:0060911 |
cardiac cell fate commitment(GO:0060911) |
| 0.0 |
0.2 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.0 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.0 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 |
0.0 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.1 |
GO:0030204 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) chondroitin sulfate metabolic process(GO:0030204) chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
| 0.0 |
0.1 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.0 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.0 |
0.1 |
GO:0071868 |
cellular response to monoamine stimulus(GO:0071868) cellular response to catecholamine stimulus(GO:0071870) |
| 0.0 |
0.2 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.0 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.0 |
0.3 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.1 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.0 |
0.1 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.0 |
0.0 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.0 |
0.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.0 |
0.0 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.0 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.0 |
0.1 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.0 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.0 |
GO:0035195 |
gene silencing by miRNA(GO:0035195) |
| 0.0 |
0.1 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.0 |
0.1 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.0 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.0 |
0.0 |
GO:1900125 |
regulation of hyaluronan biosynthetic process(GO:1900125) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.0 |
0.1 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.0 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.0 |
0.1 |
GO:0015807 |
L-amino acid transport(GO:0015807) |
| 0.0 |
0.1 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.3 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.0 |
0.0 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 |
0.0 |
GO:0051654 |
establishment of mitochondrion localization(GO:0051654) |
| 0.0 |
0.5 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.0 |
0.2 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.0 |
GO:0001832 |
blastocyst growth(GO:0001832) |
| 0.0 |
0.0 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.0 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.0 |
0.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 |
0.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.0 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.0 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
